Assessment and definitive diagnosis
If a patient presents with coughing, tachypnea (fast and difficult breathing), fever, chills, pleuritic pain or chest discomfort, crackles, headache, vomiting, excessive sweating, rapid heart rate, and low BP with generalized weakness, CAP should be suspected. Confusion, lethargy, and fatigue with underlying hypoxia may be present in older patients. The patient may also exhibit anxious behaviors, be unable to find a comfortable lying position, and instead assume a tripod sitting position in an effort to expand chest capacity.
The absence of any of these symptoms doesn't preclude a diagnosis of CAP. Note that most patients with CAP will have tachypnea, but most patients with tachypnea won't have CAP.
If there's an abnormality on a chest X-ray, a question of respiratory infection contracted outside the hospital, or if the patient has had a recent history of an upper respiratory infection or influenza, CAP should be considered and an appropriate assessment should be made.
Focused assessment of the respiratory system will likely reveal unequal or diminished chest expansion upon inspiration and use of accessory muscles. Upon auscultation, crackles may be heard over the consolidated lung or involved lobe, and wheezing may be present as a result of inflammation and restricted airways from the accumulation of exudate. Increased tactile fremitus, bronchial breath sounds, and dullness to percussion indicate consolidation. Decreased tactile fremitus is indicative of pleural effusion. The sputum of the patient with bacterial CAP infection will be purulent, thick, sticky, and yellow in color. The patient may also have foul-smelling breath.
A chest X-ray is the best way to determine if the patient has pneumonia. The chest X-ray provides information needed to make a definitive diagnosis of CAP and shows evidence of any underlying pulmonary complications. Bacterial and viral infections present differently. Scattered or localized infiltrates suggest bacterial infections. Diffuse and extensive nodular infiltrates indicate viral infections.
Sputum and nasopharyngeal samples provide information about the specific organism and sensitivity to specific antibiotic therapy. Serologic testing, blood cultures, and urine antigen testing are also recommended.
Bronchoalveolar lavage and needle thoracentesis yield useful information, but are invasive and difficult to use in children and some older people. As with any diagnostic testing, the choice of method will be somewhat determined by the patient's ability to provide the sample or undergo the procedure.
Guidelines to improve care and outcomes
Given the high mortality rate and costs associated with CAP, it's crucial to consider the severity of the disease and the risk associated with inpatient versus outpatient care. Best practice guidelines and risk scales help the healthcare provider ascertain the nature of treatment. The CURB-65 severity score for CAP and the Pneumonia Severity Index (PSI) are two ways that patients' risks for complications and care needs can be quantified. These comprehensive, data-driven risk assessment tools were developed by the Infectious Disease Society of America and the American Thoracic Society to help healthcare providers make care recommendations for patients with CAP.
CURB-65 is a severity risk index used to determine the type of medical treatment needed and the best location for the treatment. The acronym CURB-65 stands for:
- uremia (blood urea nitrogen level greater than or equal to 20 mg/dL)
- respirations greater than or equal to 30 breaths/minute
- low BP, requiring fluids
- age over 65.
A patient diagnosed with CAP who has two or more of these criteria is hospitalized.
The PSI, a more comprehensive instrument, uses a predication model algorithm to help the healthcare provider determine the best site of care. Data used to determine the patient's risk status include demographic variables, presence or absence of comorbid diseases, physical exam, and lab values. After the data are compiled and evaluated, the patient is classified along a scale from I (low risk) to V (high risk). Patients who are classified in risk categories I to III are considered safe to receive outpatient treatment. Those in categories IV or V are hospitalized.
These standardized risk assessment guidelines, in combination with good clinical judgment and effective treatment modalities, can help improve the outcomes of patients with CAP.
Treatments at the ready
Antibiotics and over-the-counter (OTC) drugs, coupled with visits to the healthcare provider, are used for patients with lower risk diagnoses of CAP caused by bacterial sources. In general, patients diagnosed with mild-to-moderate bacterial CAP are treated as outpatients and are usually given macrolides such as erythromycin, clarithromycin, and azithromycin or doxycycline. Respiratory fluoroquinolones such as levofloxacin, moxifloxacin, and gemifloxacin are the drugs of choice for patients who have considerable comorbidities, are allergic to the macrolides, or have a history of drug-resistant pneumonia.
Higher-risk patients may be admitted to the hospital and even placed in the ICU if the disease has been assessed as critical and the patient isn't able to receive adequate care as an outpatient. See Sample treatment algorithm for a patient with suspected CAP.
Immediate use of antibiotics is critical for successful recovery of a patient diagnosed with CAP caused by bacterial sources. The type of drug and route of delivery are determined by the severity of the illness, the causal organism, and individual patient risk factors such as comorbidities and prior antibiotic use. Oral drug therapy is preferred; patients who need I.V. treatment are switched to oral antibiotics within 48 hours after initial therapy or as soon as their condition allows.
Viral CAP, caused by pathogens such as RSV, adenoviruses, or influenza-type viruses, is often a secondary infection after a person has had a cold or the flu. It's important to remember that viral CAP isn't treated with antibacterial drugs. There are antiviral drugs available, such as oseltamivir, zanamivir, and acyclovir, which can be used to treat the infection. The drug of choice depends on the type of organism identified by isolating the virus in cultures or the presence of antibodies that suggest your patient had a previous infection.
Antiviral drugs must be started within 48 hours of the symptoms occurring to be effective. Most often, viral CAP is treated symptomatically or with supportive care such as hydration, rest, and taking OTC medications as recommended by the healthcare provider to relieve fever, cough, and generalized achiness. If viral CAP doesn't get treated, the worst case scenario is that patients may develop a bacterial infection on top of the viral infection they have already. If a patient's symptoms worsen, the healthcare provider should be contacted.
Your care is needed
Regardless of setting, your patient requires close monitoring of vital signs, especially respiratory function. This includes sputum production and quality, oxygenation, and activity tolerance. Tracking fluid input and output and nutritional status gives you information about the patient's general condition. Monitoring lab values such as white blood cell counts, serology, and sputum cultures ensures that your patient is receiving adequate and appropriate antibiotic therapy. Be sure that follow-up chest X-rays are ordered.
You need to know your patient's health history to determine prior antibiotic use and any allergies to medications. Be sure that all medications are administered and taken as prescribed.
If your patient is hospitalized or requires I.V. medications, make sure that all I.V. lines are accessible and patent. When your patient is switched to oral antibiotics, teach him or her the importance of completing the prescribed course of treatment. Remind your patient that failure to take medicine even when feeling better can led to a recurrence of CAP or another type of infection.
Potential complications from CAP include the development of an abscess (a pus filled sac or cavity); respiratory failure (the leading cause of death in patients with pneumonia); and acute respiratory distress syndrome (ARDS), which often leads to failure of the lungs. Another conceivable complication is bacteremia, a condition in which bacteria enter the bloodstream, causing an infection of the blood. Pleural effusion, in which fluid builds up around the two-layered membranes that surround the lungs (pleura), is another complication of CAP. Although the pleura naturally have a small amount of fluid in them, an excess of fluid can lead to more respiratory distress for the patient, who may present with pain or shortness of breath. If CAP is left untreated, the worst case scenario is a possible fatality, especially in high risk patients, such as the elderly, the very young, pregnant women, and patients with immune system problems or disorders.
In addition to the physical distress of CAP, patients often feel a decrease in their quality of life as a result of isolation and loss of work while being treated for CAP. Families also feel the burden of caring for a patient diagnosed with CAP. Routines are disrupted and caregivers may lose time from work and may be susceptible to contracting this infectious disease.
Teach your patient that infectious diseases can be prevented. The first line of defense against any infectious illness is good hand hygiene and personal care to minimize the spread of diseases. Another protective avenue is immunizations. Find out if your patient has been immunized against influenza and pneumonia. There are vaccines available to prevent pneumonia and associated respiratory illness. The 23-valent polysaccharide pneumococcal vaccine for adults and the influenza vaccine reduce the incidence of disease and subsequent need for treatment or hospitalization associated with pneumonia or influenza. Vaccines that help reduce the incidence of pneumonia in children include H. influenzae type b, measles, pneumococcal conjugate vaccine, pertussis, and rotavirus. Remember, a diagnosis of CAP can be avoided if your patients take precautions.
CAP is a preventable disease, although certain factors may be present for some people that will make treatment and recovery more difficult than for others. Don't underestimate your role as a teacher. Take a public health approach and help your own community fight locally to help diminish this global health crisis.
Whether you're treating an outpatient or attending to a patient in the hospital, it's essential that you teach your patient with CAP to follow these instructions. Tell your patients to "Mind the DRAFT."
Drink liquids and eat healthily.
Report abnormal signs or symptoms.
Ambulate. Engage in moderate activity if not contraindicated. The more reasonably active a patient stays, the better the chance of recovery.
Finish all courses of medications completely. Report any adverse reactions immediately.
Turn away from behaviors that endanger health such as smoking.
Here are a few steps that you can take to help stop CAP in its tracks. Take the following "CWIS" to see whether you're doing all you can to help your community fight CAP.
Cover your mouth and nose when coughing or sneezing. Teach your patients to cough or sneeze into their shoulders, not into their hands.
Wash your hands often and thoroughly and teach your patients to do the same.
Immunize! Seek information about where to get the flu vaccine. There are also different and appropriate pneumonia vaccines for children and adults.
Stay home from work or school when you're sick. Stop the spread of disease by considering isolating yourself from the community until you get better.
Learn more about it
. Agency for Healthcare Research and Quality. Pneumonia Severity Index calculator.
. Burke, CA. Pneumonia, community-acquired.
. CDC. Fast stats: Pneumonia.
. CDC. Pneumonia among children in developing countries.
. CDC. Pneumonia can be prevented—vaccines can help.
. Ebell MH. CURB-65 and CRB-65 severity scores for community-acquired pneumonia.
Kronman MP, Shah SS. Pediatric community-acquired pneumonia: current challenges in the outpatient diagnosis. Contemporary Pediatrics
Lutfiyya MN, Henley E, Chang LF, Reyburn SW. Diagnosis and treatment of community-acquired pneumonia. Am Fam Physician
. Madhi SA, Levine OS, Hajjeh R, Mansoor OD, Cherian T. Vaccines to prevent pneumonia and improve child survival.
. Mandell LM, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.
Pathophysiology Made Incredibly Visual!
Philadelphia, PA: Lippincott Williams & Wilkins; 2008:61.
Smeltzer S, Bare B, Hinkle J, Cheever K. Brunner and Suddarth's Textbook of Medical-Surgical Nursing
. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:630–631,639.
© 2011 Lippincott Williams & Wilkins, Inc.
Workman ML. Care of patients with infectious respiratory problems. In Ignatavicius D, Workman ML (eds). Medical-Surgical Nursing: Patient-Centered Collaborative Care
. 6th ed. St. Louis, MO: Saunders Elsevier, Inc.; 2010:653–676.